Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care.

Biotechnology

Karuna Therapeutics

Bill Meury

Steven Paul

Tanya Glidden

Amanda Orban

Stephanie Hodges

Alicia Meli

Frank Truslow

Jackie Cohen

Gregg Pratt

Mia Kelley

Will Kane

Andrew Miller

Troy A. Ignelzi

Stephen Brannan

The Directors at Karuna Therapeutics are responsible for strategic leadership and oversight across various departments, ensuring alignment with the company’s mission to develop groundbreaking therapies for CNS disorders. They drive key initiatives in procurement, corporate communications, market access, market research, revenue management, learning and development, and publications. This team plays a pivotal role in steering the company towards innovative therapeutic pathways and advancing the standard of care for neuropsychiatric patients.

Directors

Medical and Clinical Operations

Leadership Team

Directors

About

Team members

Other teams at Karuna Therapeutics

Medical and Clinical Operations

Leadership Team